孟鲁司特(montelukast)是一种口服的选择性白三烯受体拮抗剂,通过有效抑制白三烯C4、D4、E4与其受体结合,可防止支气管收缩、减少嗜酸性粒细胞聚集与黏液分泌[1]。临床中主要用于哮喘的预防和治疗,同时也用于减轻过敏性鼻炎引起的症状[2]。孟鲁司特常见的不良反应主要为头痛、头晕、咳嗽、鼻塞、鼻衄、发热、皮疹、流 Montelukast, an oral and selective leukotriene receptor antagonist, prevents bronchoconstriction and reduces eosinophil accumulation by effectively inhibiting the binding of leukotrienes C4, D4 and E4 to their receptors Mucus secretion [1]. Clinical mainly for the prevention and treatment of asthma, but also for alleviating the symptoms caused by allergic rhinitis [2]. Montelukast common adverse reactions are mainly headache, dizziness, cough, stuffy nose, epistaxis, fever, rash, flow